Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep278 | Calcium and Vitamin D metabolism | ECE2015

25-OH vitamin D: a predictor of clinical outcomes in primary hyperparathyroidism

Sahin Mustafa , Aycicek Gozde Sengul , Corapcioglu Demet , Emral Rifat , Gullu Sevim , Erdogan Murat Faik , Gedik Vedia Tonyukuk , Baskal Nilgun , Uysal Ali Riza

Objectives: We aimed to find if there is any relationship between vitamin D levels and clinical, laboratory parameters and osteoporosis, in primary hyperparathyroidism (PHPT).Material and methods: 128 patients with PHPT and 30 patients as a control group were analysed. Patients with PHPT were grouped due to vitamin D levels and levels low than 20 μg/ml accepted as deficiency.Results: Patients with 25-OH vitamin D <20 &#956...

ea0037ep823 | Pituitary: clinical | ECE2015

Clinical features and treatment outcomes of resistant acromegaly patients: a single-centre study

Demir Ozgur , Canpolat Asena Gokcay , Aydogan Berna Imge , Keskin Caglar , Canlar Sule , Sahin Mustafa , Emral Rifat , Gullu Sevim , Gedik Vedia Tonyukuk , Uysal Ali Riza , Corapcioglu Demet

Introduction: Disease control in acromegaly can be achieved by surgery, medical treatment, and radiotherapy either alone or in combination. The acromegaly patients whom tumour shrinkage cannot be provided or growth hormone levels do not decrease under multiple treatment modalities are designated as resistant acromegaly. We aimed in our study to evaluate the clinical features of resistant acromegaly patients and determine their responds to different treatment modalities.<p ...

ea0037ep900 | Thyroid cancer | ECE2015

Concomitant thyroid nodules in primary hyperparathyroidism

Sahin Mustafa , aycicek Gozde Sengul , corapcioglu Demet , emral Rifat , gullu Sevim , erdogan Murat Faik , Gedik Vedia Tonyukuk , Baskal Nilgun , Uysal Ali Riza

Objectives: Coexisting thyroid nodules affect the treatment choice for PHPT. We aimed to evaluate the incidence of concomitant thyroid nodules in patients with primary hyperparathyroidism and to investigate the relationship between thyroid nodule volume, thyroid gland volume and thyroid nodules with clinical and laboratory parameters.Materials and methods: This study was carried out at Ankara University Endocrinology and Metabolism Department. 183 patien...

ea0020p604 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Results of acromegaly patients treated with surgery and/or somatostatin analog and/or radiotherapy in a University Hospital in Turkey

Demir Ozgur , Tonyukuk Gedik Vedia , Emral Rifat , Faik Erdogan Murat , Gullu Sevim , Corapcioglu Demet , Uysal Ali Riza , Baskal Nilgun , Kamel Nuri

Background: Transsphenoidal adenomectomy is the first choice of therapy, but about 50% of patients are not cured and require medical treatment and/or radiotherapy. We retrospectively analyzed the data on surgery, sandostatin analog therapy, radiotherapy and the combination of them.Materials-methods: The records of the 96 female and 70 male, totally 166 acromegalic patients who had been followed in Ankara University, Endocrinology and Metabolic Diseases D...

ea0049ep967 | Pituitary - Clinical | ECE2017

Is there a role of immunohistochemical expression of pituitary hormones and proliferative marker ki-67 on long-term outcome in our acromegalic patients?

Sahin Mustafa , Keskin Caglar , Kiremitci Saba , Erden Esra , Canpolat Asena , Cinel Murat , Canlar Sule , Demir Ozgur , Gullu Sevim , Emral Rifat , Erdogan Murat Faik , Gedik Vedia , Baskal Nilgun , Corapcioglu Demet

Expression of hormones other than GH may affect the prognosis in acromegalic patients. Generally, Ki-67 is a well-known proliferative index used to predict remission in pituitary adenomas. We aimed to evaluate the relationship of immunohistochemical expression pituitary hormones, ki-67 and remission. Also we evaluated the role of pre, post-operative clinical and laboratory values, pathological characteristics on long-term remission. We included 64 acromegaly patients that were...